Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [1][5]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by December 2, 2025 [3]. - The lawsuit alleges that Molina failed to disclose critical information regarding its medical cost trend assumptions and the impact on its financial guidance for fiscal year 2025 [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [4]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [4]. Group 3: Case Specifics - The lawsuit claims that Molina's near-term growth was reliant on a lack of utilization of various health services, which was not disclosed to investors [5]. - The misleading positive statements made by Molina regarding its business operations and prospects are central to the claims in the lawsuit [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Molina Healthcare, Inc. securities between February 5, 2025, and July 23, 2025, of the December 2, 2025, deadline to become lead plaintiffs in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Molina securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [2]. - The lawsuit alleges that Molina failed to disclose several material adverse facts regarding its financial health and operational assumptions, which misled investors [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering significant amounts for investors [3]. - The firm has been recognized for its leadership in securities class action settlements, achieving notable recoveries, including over $438 million in 2019 alone [3]. Group 3: Case Specifics - The lawsuit claims that Molina's financial guidance for fiscal year 2025 was likely to be cut due to undisclosed adverse facts, which included issues with medical cost trend assumptions and a dislocation between premium rates and medical costs [4]. - The misleading positive statements made by Molina regarding its business operations and prospects are central to the claims made in the lawsuit [4].

Core Viewpoint - Molina Healthcare, Inc. is facing a class action lawsuit due to allegations of false statements and concealment of material facts regarding its financial health and operational assumptions, which led to a significant drop in its stock price [3]. Summary by Sections Class Action Details - The class period for the lawsuit is from February 5, 2025, to July 23, 2025 [3]. - Allegations include misleading statements about the company's medical cost trend assumptions and the dislocation between premium rates and medical costs [3]. Financial Implications - The lawsuit claims that Molina's near-term growth relied on reduced utilization of various health services, which could lead to a substantial cut in financial guidance for fiscal year 2025 [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by December 2, 2025, to potentially become lead plaintiffs and participate in recovery efforts [4]. - Registration provides access to portfolio monitoring software for updates on the case [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5].

Core Points - Class action lawsuits have been filed on behalf of shareholders of several publicly-traded companies, with specific deadlines for filing lead plaintiff motions [1] Company Summaries Molina Healthcare, Inc. (NYSE: MOH) - Class Period: February 5, 2025 – July 23, 2025 - Allegations include false and misleading statements regarding medical cost trend assumptions, dislocation between premium rates and medical costs, and reliance on reduced utilization of services, leading to likely cuts in financial guidance for fiscal year 2025 [2] Marex Group plc (NASDAQ: MRX) - Class Period: May 16, 2024 – August 5, 2025 - Allegations include selling over-the-counter financial instruments to itself, inconsistencies in financial statements, and reliance issues with financial statements, resulting in misleading positive statements about the company's operations and prospects [3] WPP plc (NYSE: WPP) - Class Period: February 27, 2025 – July 8, 2025 - Allegations include the media arm's inability to handle macroeconomic challenges and loss of market share, leading to misleading positive statements about the company's business and operations [4]

Group 1 - Oscar Health shares increased by 20.9% following the announcement of a proposal to extend subsidies in the Affordable Care Act for two more years [1] - Centene's stock rose by 8.5% as a result of the same proposal [1] - Molina Healthcare experienced a 6.7% increase in its stock price, also linked to the subsidy extension news [1] Group 2 - Novo Nordisk's shares fell by 9.6% after a failed trial for an Alzheimer's drug [1] - Google's stock rose by 4.0%, driven by the continued popularity of its Gemini 3 Pro [1] - Tesla's shares increased by 2.4%, with Elon Musk announcing the imminent completion of the development of the new AI chip A15 [1] - Alibaba's stock saw a 4.4% rise, with its Qianwen app surpassing 10 million users within a week of public testing [1]

Accessibility StatementSkip Navigation NEW YORK, Nov. 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Molina Healthcare, Inc. (NYSE: MOH). Shareholders who purchased shares of MOH during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/molina-healthcare-inc-loss-submission-form/ ...

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 2, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 2, 2025 [3]. - The lawsuit claims that Molina failed to disclose several material adverse facts regarding its financial health, which misled investors [5]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [4]. - The Rosen Law Firm has a history of successful settlements in securities class actions, including a record settlement against a Chinese company and significant recoveries for investors in recent years [4]. Group 3: Case Specifics - The lawsuit alleges that Molina's management misrepresented the company's medical cost trend assumptions and financial guidance for fiscal year 2025, leading to investor damages when the true information was revealed [5].

Group 1 - The article discusses a class action lawsuit on behalf of purchasers of securities of Molina Healthcare, Inc. (NYSE: MOH) for the period between February 5, 2025, and July 23, 2025 [1] - Molina Healthcare is identified as a health insurance company [1] - The Rosen Law Firm is investigating allegations related to the class action lawsuit [1]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Molina Healthcare, Inc. for alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by December 2, 2025 [2][5]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is encouraging investors who suffered losses in Molina to contact them regarding their legal rights [1][2]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. Allegations Against Molina - The complaint alleges that Molina and its executives made false or misleading statements and failed to disclose material adverse facts regarding the company's medical cost trend assumptions [5]. - Specific issues cited include a dislocation between premium rates and medical costs, dependence on low utilization of various health services, and the likelihood of cutting financial guidance for fiscal year 2025 [5]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter financial results, revealing adjusted earnings of approximately $5.50 per share, which was below prior expectations due to medical cost pressures [6]. - The company cut its full-year adjusted earnings per share guidance by 10.2%, from at least $24.50 to a range of $21.50 to $22.50 [7]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share [7]. - On July 23, 2025, Molina further slashed its full-year earnings guidance, reporting a GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year over year [8]. - The new guidance indicated a 13.6% cut to earnings per share, with full-year GAAP net income guidance reduced by 27% to $912 million [8]. - This led to a significant drop in Molina's stock price by $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [8].

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. who incurred losses exceeding $100,000 during the specified class period to seek legal counsel before the December 2, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased Molina securities between February 5, 2025, and July 23, 2025, may be eligible for compensation without any upfront fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by December 2, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [4]. Group 2: Allegations Against Molina Healthcare - The lawsuit alleges that Molina failed to disclose several material adverse facts, including issues related to medical cost trend assumptions and a dislocation between premium rates and medical costs [5]. - It is claimed that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a significant reduction in financial guidance for fiscal year 2025 [5]. - The lawsuit asserts that the positive statements made by Molina regarding its business and operations were materially misleading and lacked a reasonable basis [5].